Artal Group S.A.
- SEC CIK
- 0001053906
- 最新申報
- 2026/8/13
2022 年第 1 季持倉
持倉截至 2022/3/31，2022/5/12 申報。只含多頭部位，變化是跟 2021 年第 4 季比股數。
- 持股檔數
- 135
- 較 2021 年第 4 季 −9
- 總值
- $23.7 億
- 較 2021 年第 4 季 −$10.4 億 (−30.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ARGXArgenx SE | SPONSORED ADR | 587,500 | $1.85 億 | 7.8% | +87,500+17.5% | 加碼 | 歷史 |
| WWWW International, Inc. | COM | 14,818,300 | $1.52 億 | 6.4% | 00.0% | 不變 | 歷史 |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 71,178,364 | $1.49 億 | 6.3% | 00.0% | 不變 | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 665,000 | $1.25 億 | 5.3% | −10,000−1.5% | 減碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 1,350,000 | $1.11 億 | 4.7% | −50,000−3.6% | 減碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 650,000 | $1.06 億 | 4.5% | 00.0% | 不變 | 歷史 |
| SGENSeagen Inc. | COM | 650,000 | $9,363 萬 | 4.0% | +150,000+30.0% | 加碼 | 歷史 |
| FATEFate Therapeutics Inc | COM | 2,000,000 | $7,754 萬 | 3.3% | +200,000+11.1% | 加碼 | 歷史 |
| SEERSeer, Inc. | COM CL A | 4,750,000 | $7,239 萬 | 3.1% | 00.0% | 不變 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 1,650,000 | $6,625 萬 | 2.8% | +64,951+4.1% | 加碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 8,500,000 | $5,848 萬 | 2.5% | 00.0% | 不變 | – |
| IGMSIGM Biosciences, Inc. | COM | 2,000,000 | $5,346 萬 | 2.3% | +500,000+33.3% | 加碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 1,500,000 | $5,252 萬 | 2.2% | 00.0% | 不變 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 850,000 | $4,797 萬 | 2.0% | 00.0% | 不變 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 1,000,000 | $4,232 萬 | 1.8% | 00.0% | 不變 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 4,000,000 | $3,788 萬 | 1.6% | −2,000,000−33.3% | 減碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 1,000,000 | $3,681 萬 | 1.6% | 00.0% | 不變 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 500,000 | $3,327 萬 | 1.4% | −200,000−28.6% | 減碼 | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 2,450,000 | $3,158 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| ERASErasca, Inc. | COM | 3,172,221 | $2,728 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| FHTXFoghorn Therapeutics Inc. | COM | 1,720,720 | $2,621 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| SAGESage Therapeutics, Inc. | COM | 750,000 | $2,483 萬 | 1.0% | −250,000−25.0% | 減碼 | 歷史 |
| SDGRSchrodinger, Inc. | COM | 700,000 | $2,388 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 700,000 | $2,095 萬 | 0.9% | −50,000−6.7% | 減碼 | 歷史 |
| GBIOGeneration Bio Co. | COM | 2,814,191 | $2,066 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 2,358,968 | $2,048 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| RUBYRubius Therapeutics, Inc. | COM | 3,701,580 | $2,040 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 2,064,262 | $2,031 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 275,000 | $1,998 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| DNLIDenali Therapeutics Inc. | COM | 600,000 | $1,930 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 800,100 | $1,895 萬 | 0.8% | −449,900−36.0% | 減碼 | 歷史 |
| EVOEvotec SE | SPONSORED ADS | 1,149,425 | $1,739 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| KURAKura Oncology, Inc. | COM | 1,050,000 | $1,688 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| EQRXEQRx, Inc. | COM | 4,000,000 | $1,652 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| KLRSKalaris Therapeutics, Inc. | COM | 2,323,371 | $1,568 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| REPLReplimune Group, Inc. | COM | 900,000 | $1,528 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 2,273,530 | $1,419 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| APTXAptinyx Inc. | COM | 6,116,493 | $1,388 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| NBPNovaBridge Biosciences | SPONSORED ADS | 850,000 | $1,380 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| AGENAgenus Inc | COM NEW | 5,500,000 | $1,353 萬 | 0.6% | −1,000,000−15.4% | 減碼 | 歷史 |
| ITOSiTeos Therapeutics, Inc. | COM | 400,000 | $1,287 萬 | 0.5% | −144,047−26.5% | 減碼 | 歷史 |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,000,000 | $1,238 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM | 1,200,000 | $1,225 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| KRONKronos Bio, Inc. | COM | 1,542,954 | $1,116 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 200,000 | $1,016 萬 | 0.4% | +200,000 | 新進 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 700,000 | $996.8 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| IMAImageneBio, Inc. | COM | 1,549,513 | $945.2 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 1,000,000 | $935.0 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 1,000,000 | $930.0 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ATRAAtara Biotherapeutics, Inc. | COM | 1,000,000 | $929.0 萬 | 0.4% | −500,000−33.3% | 減碼 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 400,000 | $912.8 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 2,152,291 | $886.7 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 2,200,000 | $877.8 萬 | 0.4% | +1,000,000+83.3% | 加碼 | 歷史 |
| ALXOAlx Oncology Holdings Inc | COM | 500,000 | $845.0 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| Exscientia PLC30223G102 | ADS | 550,000 | $792.0 萬 | 0.3% | 00.0% | 不變 | – |
| IMUXImmunic, Inc. | COM | 700,000 | $791.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| VIGLVigil Neuroscience, Inc. | COM | 1,121,191 | $788.2 萬 | 0.3% | +1,121,191 | 新進 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 2,500,000 | $785.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| SQZSQZ Biotechnologies Co | COM | 1,606,309 | $772.6 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 800,000 | $760.8 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| OTLYOatly Group AB | SPONSORED ADS | 1,500,000 | $751.5 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,000,000 | $744.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| Omega Alpha SpacG6749V107 | CL A | 750,000 | $736.5 萬 | 0.3% | 00.0% | 不變 | – |
| CYPHCypherpunk Technologies Inc. | COM | 4,000,000 | $700.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| SESea Ltd | SPONSORD ADS | 57,500 | $688.8 萬 | 0.3% | +57,500 | 新進 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,040,882 | $678.7 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,255,375 | $663.1 萬 | 0.3% | 00.0% | 不變 | – |
| DSGNDesign Therapeutics, Inc. | COM | 400,000 | $646.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 200,000 | $598.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| FUSNFusion Pharmaceuticals Inc. | COM | 750,000 | $582.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CFRXCONTRAFECT Corp | COM NEW | 1,500,000 | $547.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 593,030 | $531.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 250,000 | $526.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 525,000 | $506.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| NEXINexImmune, Inc. | COM | 1,200,000 | $505.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| HARPHarpoon Therapeutics, Inc. | COM | 1,000,000 | $497.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Dynamics Special Purpose Cor268010105 | CLASS A COM | 500,000 | $493.5 萬 | 0.2% | 00.0% | 不變 | – |
| RNACCartesian Therapeutics, Inc. | COM | 4,000,000 | $492.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| TILInstil Bio, Inc. | COM | 450,000 | $483.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| YMABY-mAbs Therapeutics, Inc. | COM | 400,000 | $475.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 250,000 | $461.8 萬 | 0.2% | 00.0% | 不變 | – |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 1,646,517 | $456.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IVVDInvivyd, Inc. | COM | 1,000,000 | $456.0 萬 | 0.2% | +1,000,000 | 新進 | 歷史 |
| SPROSpero Therapeutics, Inc. | COM | 500,000 | $435.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| HOOKHOOKIPA Pharma Inc. | COM | 1,849,616 | $421.7 萬 | 0.2% | +1,250,000+208.5% | 加碼 | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM | 3,500,000 | $416.5 萬 | 0.2% | +500,000+16.7% | 加碼 | 歷史 |
| MIRMirion Technologies, Inc. | COM CL A | 500,000 | $403.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ACIUAC Immune SA | SHS | 1,000,000 | $400.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ADVMAdverum Biotechnologies, Inc. | COM | 3,000,000 | $393.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| PFTAPerception Capital Corp. III | CLASS A ORD SHS | 380,000 | $377.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 3,000,000 | $360.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 700,000 | $357.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| LYELLyell Immunopharma, Inc. | COM | 700,000 | $353.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ADAGAdagene Inc. | ADS | 1,000,000 | $350.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| VORVor Biopharma Inc. | COM | 550,000 | $332.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SANASana Biotechnology, Inc. | COM | 400,000 | $330.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 450,000 | $322.2 萬 | 0.1% | +250,000+125.0% | 加碼 | 歷史 |
| XLOXilio Therapeutics, Inc. | COM | 450,000 | $318.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CRISCuris Inc | COM NEW | 1,300,000 | $309.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| GRTSGritstone bio, Inc. | COM | 750,000 | $309.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2021 年第 4 季之後清倉（16 檔）
2021 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 4 季股數 | 2021 年第 4 季市值 | 2021 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| NGNovagold Resources Inc | COM NEW | 2,600,000 | $1,784 萬 | 0.5% | 歷史 |
| ALBOAlbireo Pharma, Inc. | COM | 600,000 | $1,397 萬 | 0.4% | 歷史 |
| TPTXTurning Point Therapeutics, Inc. | COM | 250,000 | $1,193 萬 | 0.4% | 歷史 |
| EVLOEvelo Biosciences, Inc. | COM | 1,000,000 | $607.0 萬 | 0.2% | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM | 1,045,000 | $496.4 萬 | 0.1% | 歷史 |
| GDSGDS Holdings Ltd | SPONSORED ADS | 100,000 | $471.6 萬 | 0.1% | 歷史 |
| IQiQIYI, Inc. | SPONSORED ADS | 1,000,000 | $456.0 萬 | 0.1% | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 200,000 | $393.4 萬 | 0.1% | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 180,500 | $294.4 萬 | 0.1% | 歷史 |
| Amryt Pharma PLC03217L106 | SPONSORED ADS | 150,480 | $162.5 萬 | <0.1% | – |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 100,000 | $97.7 萬 | <0.1% | 歷史 |
| RIGLRigel Pharmaceuticals Inc | COM NEW | 321,100 | $85.1 萬 | <0.1% | 歷史 |
| MBIIPro Farm Group, Inc. | COM | 1,048,679 | $75.5 萬 | <0.1% | 歷史 |
| RIVNRivian Automotive, Inc. | Stock | 7,000 | $72.6 萬 | <0.1% | 歷史 |
| DLOdLocal Ltd | CLASS A COM | 20,000 | $71.4 萬 | <0.1% | 歷史 |
| SURFSurface Oncology, Inc. | COM | 100,000 | $47.8 萬 | <0.1% | 歷史 |